Abstract
The successful application of thrombolytic therapy to the treatment of acute myocardial infarction has stimulated similar attempts to apply thrombolytic therapy to the treatment of acute pulmonary embolism. The development of newer thrombolytic agents and improved protocols for dosing and delivering thrombolytic therapy have provided additional insight into the risks and potential benefits of thrombolysis for acute pulmonary embolism. The purpose of the present review is to examine the risks and benefits of thrombolytic therapy for pulmonary embolism in light of recent investigations.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
